Listen to the story here.
We’ve all heard appeals to donate blood, but how have new advances in hematology changed the landscape? Is blood needed as much now as it was a decade ago?
In a recent segment of KCUR-FM’s Up to Date, UMKC Professor Jay Menitove, executive director and medical director of the Community Blood Center; and Harvey Klein, head of the department of transfusion medicine at the National Institutes of Health; talked about how new techniques have affected the amount of blood needed.
Jay Menitove is the executive director and medical director of the Community Blood Center and has served in this leadership role since 1997. He is a clinical professor of internal medicine at the University of Missouri-Kansas City and the clinical professor of pathology at the Kansas University School of Medicine. He received his M.D. at New York University School of Medicine and completed internal medicine training at Baltimore City Hospitals and Johns Hopkins Hospital. He was a hematology fellow at Case Western Reserve University Hospitals in Cleveland and completed a blood banking fellowship at the Blood Center of Southeastern Wisconsin. He is board certified in Internal Medicine, Hematology, and Blood Banking.
Harvey G. Klein is known nationally and internationally for his expertise in blood transfusion. He is widely published on such topics as transfusion-transmitted disease, the management of immunosuppressive effects of blood transfusion, and the impact of biotechnology on transfusion medicine. He co-authored the eleventh edition of Mollison’s textbook, Blood Transfusion in Clinical Medicine, and has held editorial roles with several publications, including Blood, Transfusion, Transfusion Medicine Reviews, and the Journal of Clinical Apheresis.